4.7 (269) In stock
Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.
Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery
Staying Healthy During Cancer Treatment
Lynne Pearce, Page 12
In major medical advancement, study finds additional chemo slashes risk of cervical cancer death - Good Morning America
Clinical update, Cancer Nursing Practice
Women have more side effects from cancer treatments than men
FDA Updates Highlighting the Latest Cancer Treatments, Article
New immunotherapy is approved for some people after bladder cancer surgery on the NHS in England, Wales, and Northern Ireland
Four New Technologies That Will Change The Way Cancer Is Treated
Experts call for patients to access cancer treatment without delay despite Covid pandemic
/news/-/media/images/pr%20news
